Enhancing surfactin production by using systematic CRISPRi repression to screen amino acid biosynthesis genes in Bacillus subtilis

Background Surfactin is a cyclic lipopeptide that is of great industrial use owing to its extraordinary surfactant power and antimicrobial, antiviral, and antitumor activities. Surfactin is synthesized by a condensation reaction in microbes, which uses fatty acids and four kinds of amino acids (l-glutamate, l-aspartate, l-leucine and l-valine) as precursors. Surfactin biosynthesis could be improved by increasing the supply of fatty acids; however, the effect of the regulation of amino acid metabolism on surfactin production was not yet clear. Results In this study, we aimed to improve surfactin production in B. subtilis by repressing the genes on the branch metabolic pathways of amino acid biosynthesis using CRISPRi technology. First, 20 genes were inhibited individually, resulting in 2.5- to 627-fold decreases in transcriptional level as determined by RT-qPCR. Among the 20 recombinant strains, 16 strains obtained higher surfactin titres than that produced by the parent BS168NU-Sd strain (the surfactin production of BS168NU-Sd with only dCas9 but no sgRNA expression was 0.17 g/L). In particular, the strains in which the yrpC, racE or murC genes were inhibited individually produced 0.54, 0.41, or 0.42 g/L surfactin, respectively. All three genes are related to the metabolism of l-glutamate, whose acylation is the first step in the surfactin condensation reaction. Furthermore, these three genes were repressed in combination, and the strain with co-inhibition of yrpC and racE produced 0.75 g/L surfactin, which was 4.69-fold higher than that of the parent strain. In addition, the inhibition of bkdAA and bkdAB, which are related to the metabolism of l-leucine and l-valine, not only improved surfactin production but also increased the proportion of the C14 isoform. Conclusions This study, to the best of our knowledge for the first time, systematically probed the regulatory effect of increasing the supply of amino acids on surfactin production. It provided an effective strategy and a new perspective for systematic studies on surfactin and other amino acid-derived chemicals. Electronic supplementary material The online version of this article (10.1186/s12934-019-1139-4) contains supplementary material, which is available to authorized users.


Background
Surfactin is a lipopeptide that contains two acidic amino acid residues (glutamate and aspartate), five nonpolar amino acid residues (leucine and valine) and a C 12 -C 19 β-hydroxy fatty acid chain [1,2], as shown in Fig. 1a. Surfactin is an efficient biosurfactant and has potent antimicrobial, antiviral, and antitumor activities, which are widely used in oil recovery, biopesticides, food processing, cosmetics, and pharmaceuticals [3,4]. Surfactin can be biosynthesized by many natural Bacillus subtilis strains. Despite many efforts to enhance surfactin production [5][6][7], however, the large-scale production and industrial application of surfactin remained restricted by its low production [8][9][10].
The synthesis of surfactin can be mainly divided into three parts (Fig. 1b): the biosynthesis of fatty acids that are activated to form fatty acyl-CoA by fatty acyl-CoA

Open Access
Microbial Cell Factories ligase [11]; the biosynthesis of four kinds of amino acids; and the assembly of surfactin, in which seven amino acids are assembled successively onto fatty acyl-CoA via surfactin synthase, which is encoded by the srfA operon and regulated by cell density signal and phosphopantetheinyl transferase (PPTase) Sfp. Previous studies mainly focused on the third part, and surfactin biosynthesis was enhanced by increasing the expression level of srfA. For example, Jiao et al. [8] and Sun et al. [12] enhanced surfactin production by replacing the original constitutive promoter of srfA (PsrfA) with stronger inducible Pg3 or Pspac promoters. Others achieved srfA overexpression by upregulating the quorum sensing system ComQXPA [11,[13][14][15] or downregulating the negative factors [13,14,[16][17][18][19]. Dhali et al. [20]. enhanced the production to 1556 ± 123 mg of surfactin per g dry weight of cell biomass by knocking out the global regulation factor codY, which had negative effects on srfA expression. Regarding the precursor supply, recent research suggested that increasing the supply of fatty acid precursors could greatly enhance the surfactin titre to ~ 4.9 g/L in a flask using modified synthetic medium by overexpressing the genes involved in the fatty acid biosynthesis pathway [17]. On the other hand, amino acids are also essential precursors for surfactin biosynthesis. Thus, increasing the amino acid supply might also have positive effects on surfactin production and could be achieved by decreasing the metabolism flux in the branch pathways for amino acid biosynthesis [21][22][23]. However, no such study had previously been performed. Recent advances in the field of synthetic biology are expediting our ability to regulate metabolic pathways and enhance the synthesis of target chemicals. In particular, the advent of clustered regularly interspersed short palindromic repeat interference (CRIS-PRi), which requires only the dCas9 enzyme, which is defunct in endo-nucleolytic activity because of point mutations in the RuvC and HNH domains, and a custom single guide RNA (sgRNA) that conveys the DNA binding specificity to dCas9 [24], enabling the rapid repression of gene transcription. The CRISPRi system has been successfully used to improve the biosynthesis of target chemicals by decreasing the metabolic flux of branch pathways. Lv et al. [25] downregulated the expression of sad, sucC, sucD, sdhA, and sdhB simultaneously via CRISPRi to regulate the carbon flux from succinate synthesis pathways to 4-hydroxybutyrate (4HB) biosynthesis and increased the 4HB content in the poly((3HB-co-4HB)) to 18.4 mol%. Wu et al. [23] silenced the expression of ppsA, eno, adhE, mdh, fumC, sdhA, sucC and citE simultaneously by CRISPRi and enhanced the malonyl-CoA concentration 2.3-fold. CRISPRi was also used to improve the production of polyhydroxyalkanoates [26], fatty alcohols [27], shikimic acid [28], O-methylated anthocyanin [29], and poly-β-hydroxybutyrate [30].
In this study, we tried to enhance surfactin production by increasing the supply of amino acids. First, we incorporated the surfactin biosynthesis pathway into BS168NU by expressing the exogenous sfp gene (BS168NU-S). Second, we constructed an effective CRISPRi system, as demonstrated by transcriptional repression measured by RT-qPCR. Third, the expression of 20 genes, which were selected from the branch metabolic pathways of amino acids, was perturbed individually by CRISPRi. Among the 20 recombinant strains, 16 recombinant strains gained increased surfactin production. In particular, the strains in which yrpC, racE or murC was inhibited enhanced surfactin production to 0.54, 0.41 or 0.42 g/L, respectively. Then, the three genes were further repressed in combination. The results indicated that the strains with co-inhibition of yrpC and racE obtained the highest production, which was directly related to l-glutamate metabolism, whose acylation was the first step of surfactin assembly. This work revealed that engineering the amino acid metabolism is an efficient strategy to enhance the production of surfactin.
(See figure on previous page.) Fig. 1 Schematic of surfactin biosynthesis in B. subtilis. a The chemical structure of surfactin. Surfactin is a cyclic lipopeptide consisting of a C 12 -C 19 β-hydroxy fatty acid chain and a cyclic heptapeptide consisting of four kinds of amino acids. Fatty acid chain: black; l-glutamate: purple; l-aspartate: green; l-leucine: blue; and l-valine: red. b The de novo biosynthesis of surfactin in B. subtilis. The synthesis of surfactin can be divided into three parts: the biosynthesis of fatty acids and the activation of fatty acid chains to form fatty acyl-CoA; the biosynthesis of the four kinds of amino acids; and the assembly of surfactin. The amino acids are assembled onto the fatty acyl-CoA successively via surfactin synthase. Different coloured shadings indicate different modules, including the l-valine and l-leucine metabolic modules (a. light yellow), the l-aspartate metabolic module (b. light cameo brown), and the l-glutamate metabolic module (c. light green). d-Glu: d-glutamate; d-Asp: d-aspartate; l-Asn: l-asparagine; l-dhor: l-dihydroorotate; NCBLA: N-carbamoyl-l-aspartate; l-Gln: l-glutamine; UDP-MurNAc-l-Ala: N-acetylmuramoyl-l-alanine; and UDP-MurNAc-l-Ala-d-Glu: N-acetylmuramoyl-l-alanine-d-glutamate

Genes, strains and plasmids
The sfp gene derived from Bacillus amyloliquefaciens DSM7 was synthesized by Genewiz (Suzhou, China), and the sequence is shown in Additional file 1: Table S1. All the wild-type and recombinant bacterial strains are listed in Table 1, and all the plasmids used in this work are listed in Table 2. E. coli Trans T1 was purchased from TransGen Biotech (Beijing, China) and used for gene cloning and plasmid construction. BS168 NU, constructed by our laboratory, was the starting strain for the construction of the strains for surfactin production. The pJMP1 and pJMP2 plasmids were purchased from Beijing Zhongyuan Heju Economic and Trade Co., Ltd.

Media and bacterial growth
Luria-Bertani medium (LB, 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl) was used for E. coli and B.
subtilis growth, and solid agar was used for the growth of E. coli and B. subtilis colonies.

Competent cells and translation
Competent cells were obtained as described by Anagnostopoulos and Spizizen [31]. A single colony of the receptor strain was picked up in a test tube with 5 mL of GMI medium and cultured for 14-16 h at 37 °C with shaking at 200 rpm. Then, 500 μL of broth was transferred into another test tube containing 4.5 mL of GMI medium and cultured for 4.5 h at 37 °C with shaking at 200 rpm to achieve mid-late logarithmic growth of the bacteria. Then, 750 μL of culture was transferred into another test tube containing 4.25 mL of GMII medium and cultured for 1.5 h at 37 °C with shaking at 240 rpm to obtain competent cells. Then, 0.5 to 2 μg of DNA fragment was added to 1 mL of competent cells and mixed well and the cells were then cultured for 1.5 h at 37 °C with shaking at 200 rpm. If plasmids were added, they were mixed and placed 1 h at 37 °C statically. Then, the cells were cultured for 1-1.5 h at 37 °C with shaking 240 rpm. Then, the EP tube was centrifuged for 2 min at 13,000 rpm. After removing 900 μL of the supernatant, the cells were suspended in the remaining 100 μL of supernatant, and the transformants were coated on a LB solid plate for screening. After 12-18 h of incubation at 37 °C, single colonies were obtained for further screening of transformants.

Marker-free gene modification
The method of marker-free gene modification used here for sfp gene expression was derived from Liu et al. [32]. In the chromosome BS168NU, the araR locus was replaced by the counter-selective marker cassette (Para-neo) through double crossover homologous recombination, enabling the colonies of BS168NU to grow on an Nmresistance plate. Then, the selective marker cassette (CR), which was constituted by the Cm-resistance gene (cat) and the araR gene, and the recombination fragment (upstream fragment U, downstream fragment G and homologous recombination fragment D) were integrated into the target locus in the order UDCRG. The expression of the Nm-resistance gene (neo) was repressed by the transcriptional repressor AraR, so the colonies were selected on a Cm-resistant plate. Finally, the selective marker cassette was evicted by single-crossover with homologous recombination fragment D, and the colonies were selected on an Nm-resistance plate.

sgRNA design [33]
The first CCN was identified as the protospacer adjacent motif (PAM) sequence in the non-template strand, and the following 12 bp were regarded as the seed region.
To avoid off-target effects, we searched the genome of B. subtilis 168 for the 15 bp specificity region consisting of the 12 bp 'seed' region of the sgRNA and 3 bp (CCN) PAM in the genome to rule out additional potential binding sites. If other nonspecific targets were found, the next CCN was selected as the PAM sequence, and the previous step was repeated. Then, the 20 bp after the PAM sequence were regarded as the sgRNA base-pairing region. The secondary structure of the RNA derived from the sgRNA base-pairing region and the dCas9 handle region was predicted using the UNAFold web server. If the RNA was predicted to form the correct hairpin structures, the sgRNA base-pairing region included in the corresponding primer would be synthesized, and the primer was named xxx-F, in which xxx was the name of the matching gene. If the correct hairpin structures were not formed or the strains could not grow, the next CCN was selected as the PAM sequence. The previous steps were repeated until an appropriate sgRNA was found. The sequence of the dCas9 handle region is GTT TTA GAG CTA GAA ATA GCA AGT TAA AAT AAG GCT AGT CCG . All primers used in this work were synthesized by Genewiz (Suzhou, China) and are listed in Additional file 2: Table S2.

Plasmid construction
The single gene inhibition plasmids and the multiple gene expression plasmids were constructed from the plasmid pJMP2. For the single gene interference plasmids, the different sgRNA fragments were amplified from pJMP2 by corresponding primers, digested with Acc65I and PmeI, and then ligated into the pJMP2 backbone that was digested with BsrGI and PmeI. For the multiple gene interference plasmids, the different sgRNA fragments were amplified from pJMP2 by the corresponding primers and assembled by the BM Seamless Cloning Kit, which was purchased from Biomed (Beijing, China), as shown in Fig. 5a.

RT-qPCR assay
The

Quantification of surfactin by RP-HPLC
One millilitre of fermentation broth was centrifuged for 10 min at 5000×g, and the supernatant was removed to a clean 1.5 mL centrifuge tube. The insoluble substances were removed by filtration through a 0.2 μm filter membrane (Jinlong, Tianjin, China). The concentration of surfactin was analysed by a Waters 2695 HPLC system composed of an autosampler and an UV detector (Waters, USA). A 10 μL aliquot was injected into a Symmetry ® C18 column (5 μm, 250 × 4.6 mm) (Waters, USA) to separate the surfactin isoforms. A surfactin standard (purity ≥ 98%, Sigma-Aldrich Trading Co. Ltd., Shanghai, China) was used to confirm the identity of the fractions. The mobile phases were 10% water and 90% methanol, containing 0.1% trifluoroacetic acid (TFA) with a total flow rate of 1.0 mL/min, and the chromatograms were detected at 205 nm with a column temperature of 30 °C. The total concentration of surfactin was calculated from the total peak area of four surfactin isoforms according to the concentration standard curve obtained by using Sigma surfactin.

Establishment of surfactin biosynthesis in B. subtilis 168
The wild-type B. subtilis 168 strain (BS168NU) is incapable of synthesizing surfactin since there is a termination codon in the middle of the sfp gene, which encodes the phosphopantetheinyl transferase (PPTase) that plays an essential role in surfactin synthesis [35]. Thus, we integrated the complete sfp gene into the genomic ydeO site of the wild-type B. subtilis 168 strain, which generated the recombinant BS168NU-S strain. The surfactin production by the BS168NU-S strain was 0.45 g/L, which was determined 24 h after inoculation in 5 mL of semidefined fermentation medium with sucrose as the carbon source (Additional file 3: Figure S1).

Construction of the CRISPRi system and the relative expression level analysis
Many efforts have been made to enhance surfactin production, including increasing the of fatty acid supply [17] and overexpressing surfactin synthase [8,9,12,17].
Here, we attempted to improve surfactin biosynthesis by increasing the supply of amino acid precursors, which was achieved by inhibiting the branch pathways of amino acid biosynthesis. Twenty genes on the branch pathways of amino acid biosynthesis were selected, including mmgA, yhfS, nadB, yhdR, asnB, asnH, asnO, racX, pyrB and pyrC (on the branch pathways of l-aspartate biosynthesis), purF, glnA, yrpC, racE, glmS, ybcM, murD and murC (on the branch pathways of l-glutamate biosynthesis), and bkdAA and bkdAB (on the branch pathways of l-valine and l-leucine biosynthesis) (Fig. 1b). First, these genes interfered individually with the CRIS-PRi system. Previous studies indicated that in B. subtilis 168, the expression of dCas9 by the Pxyl promoter could achieve higher inhibition efficiency than the expression of dCas9 by other promoters [36,37]. Thus, in this study, dCas9 was expressed under the control of the inducible Pxyl promoter and was integrated into the lacA site of the B. subtilis genome. The sgRNA was expressed by the constitutive Pveg promoter and integrated into the amyE site of the genome (Fig. 2a). To evaluate the silencing efficiency of the CRISPRi system in B. subtilis, the transcription levels of the 20 genes were detected by quantitative real-time PCR (qRT-PCR) with a Roche LightCycler 480. The cDNAs were obtained by reverse transcription with the total RNA extracted from 24 h fermentation broth as the template. The relative transcription level of the target gene was quantified by the 2 −ΔΔCT [34] method using the ccpA gene as the internal control and BS168NU-Sd as the calibrator. The results proved that the CRISPRi system effectively inhibited gene expression in B. subtilis 168 (Fig. 2b). However, the repression efficiencies of different genes varied. The transcription repression efficiency of mmgA, yhfS, yrpC, murC and bkdAA genes ranged from 2.5-to 7.2-fold. The transcription levels of other genes all exhibited over tenfold repression. In particular, significant decreases in the transcriptional levels of asnH, nadB, yhdR, pyrC and bkdAB genes (over 150-fold) were observed, which was consistent with a previous study [37].

Effect of single gene inhibition on surfactin production
First, BS168NU-Sd was constructed as the control by integrating the dCas9 gene into the lacA site of the BS168NU-S genome without the sgRNA cassette. Surfactin production and cell growth were determined 24 h after inoculation in 5 mL of semi-defined fermentation medium with the addition of 4 g/L xylose inducer (Fig. 3a,  b). The surfactin titre of BS168NU-Sd was only 0.17 g/L, which was lower than that of BS168NU-S (0.37 g/L). This negative impact on surfactin production resulted from the toxicity of the highly expressed dCaS9 protein [38]. Despite this effect, however, the individual inhibition of 16 among the 20 selected genes could increase the production of surfactin. In particular, when the gene yrpC, racE or murC was inhibited, the surfactin production was increased to 0.54, 0.41 or 0.42 g/L, respectively. The murC-inhibited strains also had the highest surfactin production per OD 600 of 0.083 g/L/OD 600 (Additional file 4: Figure S2). These three genes are related to the consumption of l-glutamate [39] (Fig. 1b), whose acylation is the first step in surfactin assembly.
To evaluate the differences over time, the surfactin production and cell biomass of BS168NU-Sd, yrpC, racE and murC were measured 0 h, 6 h, 12 h, 18 h, and 24 h after inoculation (Fig. 3c, d). The growth of the yrpC-and racE-inhibited strains was greater than that of the parent BS168NU-Sd strain throughout the fermentation (Fig. 3c). YrpC and RacE are MurI-type glutamate racemase [40], which not only catalyses the conversion of l-glutamate to d-glutamate [39] but also is a DNA gyrase inhibitor [40,41]. Overexpression of these MurI-type glutamate racemases caused growth retardation [40][41][42] because of the repression of DNA gyrase activity, which plays an essential role in DNA supercoiling and cell replication [43,44]. Thus, it was predicted that the inhibition of yrpC and racE could increase the growth rate, and the The OD 600 of single gene interference in the BS168NU-Sd strain with the addition of 4 g/L xylose inducer in the medium. c Changes in OD 600 in the BS168NU-Sd, yrpC, racE and murC strains. d Changes in surfactin production in the BS168NU-Sd, yrpC, racE and murC strains. The surfactin production and cell growth of the recombinant strains were all determined 24 h after inoculation in 5 mL of semi-defined fermentation medium. The different colours represent the different types of strains: light grey: wild type; green: control; light cameo brown: the strains with l-aspartate metabolic modules; light yellow: the strains with l-valine and l-leucine metabolic modules; light green: the strains with l-glutamate metabolic modules results supported this assumption, as shown in Fig. 3c. However, although the growth of the murC-inhibited strain had a longer lag period and slightly less final biomass than BS168NU-Sd, both the maximum growth rate and the volumetric productivity were higher than those of BS168NU-Sd ( Fig. 3c and Table 3). Usually, high productivity is expected to lower cell growth, since cells might redirect energy from growth to production. However, the phenomena that engineered strains could show both higher biomass and higher production were also observed in previous studies on surfactin biosynthesis [8,45] and might be caused by a higher central metabolism or higher substrate utilization rate in the engineered strains. The three engineered strains indeed used more sucrose than BS168NU-Sd, as shown in Additional file 5: Figure S3.
The mmgA-and yhfS-inhibited strains also showed clear increases in cell biomass. The genes mmgA and yhfS encode the acetyl-CoA C-acetyltransferase, which catalyses acetoacetyl-CoA biosynthesis from acetyl-CoA. The inhibition of mmgA and yhfS could reduce the consumption of acetyl-CoA, a key intracellular intermediate metabolite, which is not only used for surfactin biosynthesis but also benefits cell growth and proliferation [46].
In contrast, the strain with inhibition of pyrB or pyrC, which catalyses the conversion of l-aspartate to uracil, produced negligible amounts of surfactin. These results were consistent with previous research showing that the disruption of pyrB and pyrC decreased surfactin production [47], which indicated that high inhibition of these genes might be harmful to surfactin biosynthesis. Thus, we decreased the repression intensity by using the leaked expression of the dCas9 protein by the Pxyl promoter [37]. As expected, the pyrB-or pyrC-inhibited strains exhibited surfactin production of 0.34 or 0.36 g/L when no xylose was added (Additional file 6: Figure S4), which were much higher values than that obtained when dCas9 was induced by 4 g/L xylose (Fig. 3a). The results indicated that sometimes the gene repression efficiency needs to be delicately regulated to improve the biosynthesis of desired products.

Inhibition of bkdAA and bkdAB changed the composition of surfactin
Surfactin is a mixture in terms of the length of the fatty acid carbon chain and the structural content of the peptide moiety. Razafindralambo et al. [48] found that the foaming capacity and quality of C 14 surfactin were higher than those of C 13 and C 15 surfactin. The inhibition of bkdAA or bkdAB not only increased surfactin production compared with that of BS168NU-Sd but also significantly changed the proportion of each component of surfactin [20]. The proportion of C 14 in the bkdAA-or bkdABinhibited strain increased from 25.7% (BS168NU-S) or 18.7% (BS168NU-Sd) to 82.4% or 85.1%, respectively (Fig. 4, and Additional file 7: Figure S5) [49]. These results might occur because the inhibition of bkdAA and bkdAB not only increased the accumulation of l-leucine and l-valine, but also decreased the synthesis of iso-C 13 and iso-C 15 fatty acids by interrupting the bkd operon (lpdV, bkdAA, bkdAB and bkdB genes). The bkd operon catalyses the synthesis of iso-C 13 and iso-C 15 fatty acids using l-leucine as the precursor [49] (Additional file 8: Figure  S6). Table 3 The production, volumetric productivity and yield of the parent strains and the recombinant strains with racE, murC, yrpC, H1, H2, and H3  . 4 Effect of inhibiting bkdAA and bkdAB on the composition of surfactin. Cn represents the carbon chain lengths of β-hydroxy fatty acids, where n is the number of carbon atoms. The amino acid sequence of the heptapeptide is Glu-Leu-Leu-Val-Asp-Leu-Leu, except for C 14 -2, which has the sequence Glu-Val-Leu-Leu-Asp-Leu-Val

Multiple gene inhibition further improved surfactin production
According to the results of single gene inhibition, the three genes (yrpC, racE and murC) that most significantly increased surfactin production were selected, and their coherent co-inhibition effects on surfactin production were further studied. The sgRNA plasmids for multiple gene inhibition were constructed as shown in Fig. 5a. The surfactin production and the cell growth of the recombinant strains with multiple gene inhibition were also determined 24 h after inoculation in 5 mL of semidefined fermentation medium with 4 g/L xylose inducer (Fig. 5b). The results indicated that the simultaneous co-inhibition of two genes, i.e., yrpC and racE, yrpC and murC, or racE and murC, further increased surfactin production to 0.75, 0.57 or 0.48 g/L, respectively (as shown in the histogram of Fig. 5b). The surfactin production per OD 600 of these double-gene inhibited strains The histogram represents the production of surfactin, and the scatter represents OD 600 . c The surfactin production per OD 600 of the strains in which yrpC, racE and murC were inhibited in combination. The surfactin production and the cell growth of the recombinant strains were all determined 24 h after inoculation in 5 mL of semi-defined fermentation medium. "-" indicates the inhibition of a specific gene by CRISPRi was also increased compared to that of strains with the inhibition of a single gene (Fig. 5c). The co-inhibition of yrpC and racE produced the highest titre of surfactin (0.75 g/L). Unlike murC, the genes yrpC and racE directly participate in the consumption of l-glutamate, and thus the co-inhibition of yrpC and racE might cause a higher accumulation of l-glutamate. However, further inhibition of the three genes led to a surfactin titre of only 0.07 g/L, which was lower than that of single gene inhibition. This result may be caused by the significant deterioration in cell growth upon co-inhibition of these three genes (as shown in the scatter of Fig. 5b) [47].
In summary, we improved the capacity of surfactin production in B. subtilis by repression of the genes on the branch metabolic pathways of the biosynthesis of 4 amino acid precursors for surfactin synthesis. The production, volumetric productivity and yield of the 6 recombinant strains with the clearest improvement in surfactin synthesis are presented in Table 3. The surfactin production and volumetric productivity of the yrpC-and racE-inhibited strain were 4.51-fold that of BS168NU-Sd, and the yield on sucrose was 4.43-fold that of BS168NU-Sd. The surfactin production, volumetric productivity and yield of this recombinant strain on sucrose were also more than 2 times higher than those of BS168NU-S.